Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study.
Korotych O, Achar J, Gurbanova E, Hovhannesyan A, Lomtadze N, Ciobanu A, Skrahina A, Dravniece G, Kuksa L, Rich M, Khachatryan N, Germanovych M, Kadyrov A, Terleieva I, Akhundova I, Adenov M, Durdyeva M, Kiria N, Parpieva N, Yatskevich N, Jumayev R, Nurov R, Diktanas S, Vilc V, Migliori GB, Yedilbayev A.
Korotych O, et al. Among authors: migliori gb.
Lancet Infect Dis. 2024 Oct;24(10):1151-1161. doi: 10.1016/S1473-3099(24)00228-7. Epub 2024 Jun 13.
Lancet Infect Dis. 2024.
PMID: 38880112
Free PMC article.